SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (1063)12/12/1996 8:24:00 PM
From: richard davis   of 4342
 
Rick:

I am not a scientist, but in country boy terms, i just said the same thing. I am amazed that for such a short period of time, the response was this good.

As I just said, i would love to see AndroVir with a long term use study to compare that against the merk drug. I read that after the patient is given the Merk drug, and the virus mutates, thats the end of the patients chance of survival. They do not have anything to stop the virus at that point.

Rick Davis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News